MassRoots Approved for Google Play

“Re-gaining MassRoots’ listing on Google Play is a significant milestone that enables distribution to the millions of medical cannabis consumers that own Android devices,” stated MassRoots Chairman and CEO Mr. Isaac Dietrich. “MassRoots is already one of the most popular consumer platforms available, as evidenced by us recently announcing our 1 millionth registered user. I am confident that with this barrier to growth eliminated and several soon-to-be announced initiatives, we will be able to significantly leverage the 4/20 holiday season. We look forward to continuing to expand our market share of cannabis consumers and dispensaries to further drive shareholder value.”

About MassRoots

MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements

Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CARA breached its 50 day moving average in a Bullish Manner

CARA Therapeutics, Inc. breached its 50 day moving average in a Bullish…